Literature DB >> 17123806

Osteopontin promotes pathologic mineralization in articular cartilage.

Ann K Rosenthal1, Claudia M Gohr, Miwa Uzuki, Ikuko Masuda.   

Abstract

Calcium pyrophosphate dihydrate (CPPD) crystals are commonly found in osteoarthritic joint tissues, where they predict severe disease. Unlike other types of calcium phosphate crystals, CPPD crystals form almost exclusively in the pericellular matrix of damaged articular cartilage, suggesting a key role for the extracellular matrix milieu in their development. Osteopontin is a matricellular protein found in increased quantities in the pericellular matrix of osteoarthritic cartilage. Osteopontin modulates the formation of calcium-containing crystals in many settings. We show here that osteopontin stimulates ATP-induced CPPD crystal formation by chondrocytes in vitro. This effect is augmented by osteopontin's incorporation into extracellular matrix by transglutaminase enzymes, is only modestly affected by its phosphorylation state, and is inhibited by integrin blockers. Surprisingly, osteopontin stimulates transglutaminase activity in cultured chondrocytes in a dose-responsive manner. As elevated levels of transglutaminase activity promote extracellular matrix changes that permit CPPD crystal formation, this is one possible mechanism of action. We demonstrate the presence of osteopontin in the pericellular matrix of chondrocytes adjacent to CPPD deposits and near active transglutaminases. Thus, osteopontin may play an important role in facilitating CPPD crystal formation in articular cartilage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123806      PMCID: PMC1852442          DOI: 10.1016/j.matbio.2006.10.004

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  39 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 2.  Metabolism of extracellular pyrophosphate.

Authors:  Lawrence M Ryan; Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2003-05       Impact factor: 5.006

3.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 4.  Transglutaminases: crosslinking enzymes with pleiotropic functions.

Authors:  Laszlo Lorand; Robert M Graham
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

5.  The high prevalence of pathologic calcium crystals in pre-operative knees.

Authors:  Beth A Derfus; Jason B Kurian; Jeffrey J Butler; Laureen J Daft; Guillermo F Carrera; Lawrence M Ryan; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

6.  Importance of phosphorylation for osteopontin regulation of biomineralization.

Authors:  A Gericke; C Qin; L Spevak; Y Fujimoto; W T Butler; E S Sørensen; A L Boskey
Journal:  Calcif Tissue Int       Date:  2005-07-14       Impact factor: 4.333

Review 7.  Calcium crystals in osteoarthritis.

Authors:  Kanyakorn Jaovisidha; Ann K Rosenthal
Journal:  Curr Opin Rheumatol       Date:  2002-05       Impact factor: 5.006

8.  Effects of urinary macromolecules on hydroxyapatite crystal formation.

Authors:  Ann M Beshensky; Jeffrey A Wesson; Elaine M Worcester; Elena J Sorokina; Carl J Snyder; Jack G Kleinman
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

9.  Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage.

Authors:  Brett T Summey; Ronald D Graff; Thung-Sheng Lai; Charles S Greenberg; Greta M Lee
Journal:  J Orthop Res       Date:  2002-01       Impact factor: 3.494

10.  Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies.

Authors:  S Nalbant; J A M Martinez; T Kitumnuaypong; G Clayburne; M Sieck; H R Schumacher
Journal:  Osteoarthritis Cartilage       Date:  2003-01       Impact factor: 6.576

View more
  25 in total

1.  Immunohistochemical analysis of ageing and osteoarthritic articular cartilage.

Authors:  Neeru Goyal; Madhur Gupta; Kusum Joshi; Onkar Nath Nagi
Journal:  J Mol Histol       Date:  2010-07-11       Impact factor: 2.611

2.  Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development.

Authors:  Richard Wilson; Emma L Norris; Bent Brachvogel; Constanza Angelucci; Snezana Zivkovic; Lavinia Gordon; Bianca C Bernardo; Jacek Stermann; Kiyotoshi Sekiguchi; Jeffrey J Gorman; John F Bateman
Journal:  Mol Cell Proteomics       Date:  2011-10-11       Impact factor: 5.911

Review 3.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  Point: Hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis.

Authors:  Geraldine M McCarthy; Herman S Cheung
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

5.  Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells.

Authors:  Kristen A Johnson; Monika Polewski; Robert A Terkeltaub
Journal:  Circ Res       Date:  2008-01-17       Impact factor: 17.367

6.  Calcium deposition in osteoarthritic meniscus and meniscal cell culture.

Authors:  Yubo Sun; David R Mauerhan; Patrick R Honeycutt; Jeffrey S Kneisl; H James Norton; Natalia Zinchenko; Edward N Hanley; Helen E Gruber
Journal:  Arthritis Res Ther       Date:  2010-03-30       Impact factor: 5.156

7.  Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.

Authors:  Miwa Uzuki; Takashi Sawai; Lawrence M Ryan; Ann K Rosenthal; Ikuko Masuda
Journal:  J Rheumatol       Date:  2013-12-01       Impact factor: 4.666

Review 8.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

9.  Characterization of articular calcium-containing crystals by synchrotron FTIR.

Authors:  A K Rosenthal; E Mattson; C M Gohr; C J Hirschmugl
Journal:  Osteoarthritis Cartilage       Date:  2008-05-12       Impact factor: 6.576

10.  Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes.

Authors:  Denise L Cecil; Robert Terkeltaub
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.